Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.725 USD | +4.35% | -22.51% | +16.28% |
May. 09 | Cantor Fitzgerald Adjusts LifeMD's Price Target to $15 From $13, Keeps Overweight Rating | MT |
May. 08 | Transcript : LifeMD, Inc., Q1 2024 Earnings Call, May 08, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.28% | 381M | |
+6.06% | 32.93B | |
+18.24% | 7.94B | |
+29.59% | 4.19B | |
-25.96% | 2.8B | |
-16.87% | 1.38B | |
-33.33% | 1.17B | |
+9.72% | 966M | |
-35.73% | 900M | |
-26.60% | 839M |
- Stock Market
- Equities
- LFMD Stock
- News LifeMD, Inc.
- Cantor Fitzgerald Adjusts Price Target on LifeMD to $11 From $9, Maintains Overweight Rating